aiqbench analysis
This research proposes PRISM-DR, a specialized computer vision pipeline that deploys individual YOLO detectors for each diabetic retinopathy lesion type rather than using a single multi-class model to address class imbalance and morphological differences. By optimizing augmentation via Bayesian optimization and employing physical constraints to resolve overlapping detections, the system achieves improved performance on rare lesions compared to shared architectures. While absolute metrics remain modest due to limited training data, the study offers a practical architectural alternative for high-stakes medical imaging where specific lesion detection is critical.
PRISM-DR: Per-lesion Retinal Inference with Specialist Models for Diabetic Retinopathy
arXiv:2607.19864v1 Announce Type: cross Abstract: Diabetic retinopathy is a leading cause of preventable blindness; its early lesions are small, low contrast, and easily missed in manual screening. Most automated detectors handle the four non-proliferative DR lesions: microaneurysms, hemorrhages, hard exudates, and soft exudates, with a single multi-class model, even though these lesions differ sharply in size, color, morphology, and prevalence, so a shared model favors common, easy classes over rare, difficult ones. We present PRISM-DR, a lesion-specific pipeline that trains one single-class detector per lesion, each with its own configuration. From a raw fundus image, the pipeline applies region of interest cropping, fundus-specific preprocessing, four parallel YOLO detectors, tiling, per-lesion ensembling of five cross-validation folds, and an inter-lesion suppression step that resolves overlaps by physical lesion size and clinical priority rather than confidence. Per lesion, the best of five YOLO generations is selected, and augmentation is tuned by Bayesian optimization. Trained on IDRiD with stratified five-fold cross-validation, the system reaches a test mAP50 of 0.527 and F1 of 0.529, highest AP50 on hard exudates with 0.561. Without fine-tuning, the models transfer well where the imaging scale is close to IDRiD and degrade as field of view and resolution depart. These modest absolute results reflect a small single-source training set and a difficult task; however, treating each lesion as a separate detection problem is a practical alternative to a single multi-class model.
Abstract:Diabetic retinopathy is a leading cause of preventable blindness; its early lesions are small, low contrast, and easily missed in manual screening. Most automated detectors handle the four non-proliferative DR lesions: microaneurysms, hemorrhages, hard exudates, and soft exudates, with a single multi-class model, even though these lesions differ sharply in size, color, morphology, and prevalence, so a shared model favors common, easy classes over rare, difficult ones. We present PRISM-DR, a lesion-specific pipeline that trains one single-class detector per lesion, each with its own configuration. From a raw fundus image, the pipeline applies region of interest cropping, fundus-specific preprocessing, four parallel YOLO detectors, tiling, per-lesion ensembling of five cross-validation folds, and an inter-lesion suppression step that resolves overlaps by physical lesion size and clinical priority rather than confidence. Per lesion, the best of five YOLO generations is selected, and augmentation is tuned by Bayesian optimization. Trained on IDRiD with stratified five-fold cross-validation, the system reaches a test mAP50 of 0.527 and F1 of 0.529, highest AP50 on hard exudates with 0.561. Without fine-tuning, the models transfer well where the imaging scale is close to IDRiD and degrade as field of view and resolution depart. These modest absolute results reflect a small single-source training set and a difficult task; however, treating each lesion as a separate detection problem is a practical alternative to a single multi-class model.
Image and Video Processing (eess.IV); Artificial Intelligence (cs.AI); Computer Vision and Pattern Recognition (cs.CV)
arXiv:2607.19864 [eess.IV]
(or arXiv:2607.19864v1 [eess.IV] for this version)
https://doi.org/10.48550/arXiv.2607.19864 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 331 words
Related coverage
A Cascaded Edge-Cloud Architecture for Automated Diabetic Retinopathy Screening
arXiv · Jul 28, 2026
Explainable Diabetic Retinopathy Classification Using Vision Foundation Models
arXiv · Aug 31, 2026
From Generalist to Specialist: A Context-Fusion Framework for Endoscopic Polyp Reporting with a Frozen VLM
arXiv · Aug 18, 2026
Biomedical Imaging's Real Bottleneck Is the Data, Not the Model
Databricks · Oct 8, 2026